Global Long Acting Insulins Market Size, Status and Forecast 2020-2026
SKU ID : QYR-15133898 | Publishing Date : 28-Jan-2020 | No. of pages : 98
Detailed TOC of Global Long Acting Insulins Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Long Acting Insulins Revenue
1.4 Market Analysis by Type
1.4.1 Global Long Acting Insulins Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Insulin Glargine
1.4.3 Insulin Determir
1.4.4 Insulin Degludec
1.4.5 Long Acting Animal Insulin
1.5 Market by Application
1.5.1 Global Long Acting Insulins Market Share by Application: 2020 VS 2026
1.5.2 Home Use
1.5.3 Medical Institutions
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends by Regions
2.1 Long Acting Insulins Market Perspective (2015-2026)
2.2 Long Acting Insulins Growth Trends by Regions
2.2.1 Long Acting Insulins Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Long Acting Insulins Historic Market Share by Regions (2015-2020)
2.2.3 Long Acting Insulins Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Long Acting Insulins Market Growth Strategy
2.3.6 Primary Interviews with Key Long Acting Insulins Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Long Acting Insulins Players by Market Size
3.1.1 Global Top Long Acting Insulins Players by Revenue (2015-2020)
3.1.2 Global Long Acting Insulins Revenue Market Share by Players (2015-2020)
3.1.3 Global Long Acting Insulins Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Long Acting Insulins Market Concentration Ratio
3.2.1 Global Long Acting Insulins Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Long Acting Insulins Revenue in 2019
3.3 Long Acting Insulins Key Players Head office and Area Served
3.4 Key Players Long Acting Insulins Product Solution and Service
3.5 Date of Enter into Long Acting Insulins Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Long Acting Insulins Historic Market Size by Type (2015-2020)
4.2 Global Long Acting Insulins Forecasted Market Size by Type (2021-2026)
5 Long Acting Insulins Breakdown Data by Application (2015-2026)
5.1 Global Long Acting Insulins Market Size by Application (2015-2020)
5.2 Global Long Acting Insulins Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Long Acting Insulins Market Size (2015-2020)
6.2 Long Acting Insulins Key Players in North America (2019-2020)
6.3 North America Long Acting Insulins Market Size by Type (2015-2020)
6.4 North America Long Acting Insulins Market Size by Application (2015-2020)
7 Europe
7.1 Europe Long Acting Insulins Market Size (2015-2020)
7.2 Long Acting Insulins Key Players in Europe (2019-2020)
7.3 Europe Long Acting Insulins Market Size by Type (2015-2020)
7.4 Europe Long Acting Insulins Market Size by Application (2015-2020)
8 China
8.1 China Long Acting Insulins Market Size (2015-2020)
8.2 Long Acting Insulins Key Players in China (2019-2020)
8.3 China Long Acting Insulins Market Size by Type (2015-2020)
8.4 China Long Acting Insulins Market Size by Application (2015-2020)
9 Japan
9.1 Japan Long Acting Insulins Market Size (2015-2020)
9.2 Long Acting Insulins Key Players in Japan (2019-2020)
9.3 Japan Long Acting Insulins Market Size by Type (2015-2020)
9.4 Japan Long Acting Insulins Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Long Acting Insulins Market Size (2015-2020)
10.2 Long Acting Insulins Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Long Acting Insulins Market Size by Type (2015-2020)
10.4 Southeast Asia Long Acting Insulins Market Size by Application (2015-2020)
11 India
11.1 India Long Acting Insulins Market Size (2015-2020)
11.2 Long Acting Insulins Key Players in India (2019-2020)
11.3 India Long Acting Insulins Market Size by Type (2015-2020)
11.4 India Long Acting Insulins Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Long Acting Insulins Market Size (2015-2020)
12.2 Long Acting Insulins Key Players in Central & South America (2019-2020)
12.3 Central & South America Long Acting Insulins Market Size by Type (2015-2020)
12.4 Central & South America Long Acting Insulins Market Size by Application (2015-2020)
13Key Players Profiles
13.1 Novo Nordisk
13.1.1 Novo Nordisk Company Details
13.1.2 Novo Nordisk Business Overview and Its Total Revenue
13.1.3 Novo Nordisk Long Acting Insulins Introduction
13.1.4 Novo Nordisk Revenue in Long Acting Insulins Business (2015-2020))
13.1.5 Novo Nordisk Recent Development
13.2 Sanofi
13.2.1 Sanofi Company Details
13.2.2 Sanofi Business Overview and Its Total Revenue
13.2.3 Sanofi Long Acting Insulins Introduction
13.2.4 Sanofi Revenue in Long Acting Insulins Business (2015-2020)
13.2.5 Sanofi Recent Development
13.3 Wockhardt UK
13.3.1 Wockhardt UK Company Details
13.3.2 Wockhardt UK Business Overview and Its Total Revenue
13.3.3 Wockhardt UK Long Acting Insulins Introduction
13.3.4 Wockhardt UK Revenue in Long Acting Insulins Business (2015-2020)
13.3.5 Wockhardt UK Recent Development
14Analyst's Viewpoints/Conclusions
15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Figures, Tables and Charts Available in Global Long Acting Insulins Market Size, Status and Forecast 2020-2026
List of TablesTable 1. Long Acting Insulins Key Market Segments
Table 2. Key Players Covered: Ranking by Long Acting Insulins Revenue
Table 3. Ranking of Global Top Long Acting Insulins Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Long Acting Insulins Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Insulin Glargine
Table 6. Key Players of Insulin Determir
Table 7. Key Players of Insulin Degludec
Table 8. Key Players of Long Acting Animal Insulin
Table 9. Global Long Acting Insulins Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Long Acting Insulins Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Long Acting Insulins Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Long Acting Insulins Market Share by Regions (2015-2020)
Table 13. Global Long Acting Insulins Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Long Acting Insulins Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Long Acting Insulins Market Growth Strategy
Table 19. Main Points Interviewed from Key Long Acting Insulins Players
Table 20. Global Long Acting Insulins Revenue by Players (2015-2020) (Million US$)
Table 21. Global Long Acting Insulins Market Share by Players (2015-2020)
Table 22. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long Acting Insulins as of 2019)
Table 23. Global Long Acting Insulins by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Long Acting Insulins Product Solution and Service
Table 26. Date of Enter into Long Acting Insulins Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 29. Global Long Acting Insulins Market Size Share by Type (2015-2020)
Table 30. Global Long Acting Insulins Revenue Market Share by Type (2021-2026)
Table 31. Global Long Acting Insulins Market Size Share by Application (2015-2020)
Table 32. Global Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 33. Global Long Acting Insulins Market Size Share by Application (2021-2026)
Table 34. North America Key Players Long Acting Insulins Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Long Acting Insulins Market Share (2019-2020)
Table 36. North America Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 37. North America Long Acting Insulins Market Share by Type (2015-2020)
Table 38. North America Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 39. North America Long Acting Insulins Market Share by Application (2015-2020)
Table 40. Europe Key Players Long Acting Insulins Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Long Acting Insulins Market Share (2019-2020)
Table 42. Europe Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Long Acting Insulins Market Share by Type (2015-2020)
Table 44. Europe Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Long Acting Insulins Market Share by Application (2015-2020)
Table 46. China Key Players Long Acting Insulins Revenue (2019-2020) (Million US$)
Table 47. China Key Players Long Acting Insulins Market Share (2019-2020)
Table 48. China Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 49. China Long Acting Insulins Market Share by Type (2015-2020)
Table 50. China Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 51. China Long Acting Insulins Market Share by Application (2015-2020)
Table 52. Japan Key Players Long Acting Insulins Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Long Acting Insulins Market Share (2019-2020)
Table 54. Japan Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Long Acting Insulins Market Share by Type (2015-2020)
Table 56. Japan Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Long Acting Insulins Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Long Acting Insulins Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Long Acting Insulins Market Share (2019-2020)
Table 60. Southeast Asia Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Long Acting Insulins Market Share by Type (2015-2020)
Table 62. Southeast Asia Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Long Acting Insulins Market Share by Application (2015-2020)
Table 64. India Key Players Long Acting Insulins Revenue (2019-2020) (Million US$)
Table 65. India Key Players Long Acting Insulins Market Share (2019-2020)
Table 66. India Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 67. India Long Acting Insulins Market Share by Type (2015-2020)
Table 68. India Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 69. India Long Acting Insulins Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Long Acting Insulins Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Long Acting Insulins Market Share (2019-2020)
Table 72. Central & South America Long Acting Insulins Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Long Acting Insulins Market Share by Type (2015-2020)
Table 74. Central & South America Long Acting Insulins Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Long Acting Insulins Market Share by Application (2015-2020)
Table 76. Novo Nordisk Company Details
Table 77. Novo Nordisk Business Overview
Table 78. Novo Nordisk Product
Table 79. Novo Nordisk Revenue in Long Acting Insulins Business (2015-2020) (Million US$)
Table 80. Novo Nordisk Recent Development
Table 81. Sanofi Company Details
Table 82. Sanofi Business Overview
Table 83. Sanofi Product
Table 84. Sanofi Revenue in Long Acting Insulins Business (2015-2020) (Million US$)
Table 85. Sanofi Recent Development
Table 86. Wockhardt UK Company Details
Table 87. Wockhardt UK Business Overview
Table 88. Wockhardt UK Product
Table 89. Wockhardt UK Revenue in Long Acting Insulins Business (2015-2020) (Million US$)
Table 90. Wockhardt UK Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Long Acting Insulins Market Share by Type: 2020 VS 2026
Figure 2. Insulin Glargine Features
Figure 3. Insulin Determir Features
Figure 4. Insulin Degludec Features
Figure 5. Long Acting Animal Insulin Features
Figure 6. Global Long Acting Insulins Market Share by Application: 2020 VS 2026
Figure 7. Home Use Case Studies
Figure 8. Medical Institutions Case Studies
Figure 9. Others Case Studies
Figure 10. Long Acting Insulins Report Years Considered
Figure 11. Global Long Acting Insulins Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Long Acting Insulins Market Share by Regions: 2020 VS 2026
Figure 13. Global Long Acting Insulins Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Long Acting Insulins Market Share by Players in 2019
Figure 16. Global Top Long Acting Insulins Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Long Acting Insulins as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Long Acting Insulins Revenue in 2019
Figure 18. North America Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Long Acting Insulins Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Novo Nordisk Revenue Growth Rate in Long Acting Insulins Business (2015-2020)
Figure 27. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Sanofi Revenue Growth Rate in Long Acting Insulins Business (2015-2020)
Figure 29. Wockhardt UK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Wockhardt UK Revenue Growth Rate in Long Acting Insulins Business (2015-2020)
Figure 31. Bottom-up and Top-down Approaches for This Report
Figure 32. Data Triangulation
Figure 33. Key Executives Interviewed
Keyplayers in Global Long Acting Insulins Market Size, Status and Forecast 2020-2026
Novo NordiskSanofi
Wockhardt UK